R353Q polymorphism, activated Factor VII, and risk of premature myocardial infarction in Japanese men

Circulation Journal

Volumn 68, Issue 6, 2004, Pages 520-525

  Ogawa, Masakazu ^a   Abe, Satoshi ^a   Biro, Sadatoshi ^a   Saigo, Masahiko ^a   Kihara, Takashi ^a   Setoyama, Shiro ^b   Matsuoka, Tatsuru ^a   Toda, Hitoshi ^a   Torii, Hiroyuki ^a   Atsuchi, Yoshihiko ^a   Toyama, Yoshifumi ^a   Tateishi, Shigeki ^a   Minagoe, Shinichi ^a   Maruyama, Ikuro ^a   Tei, Chuwa ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b Kagoshima Pref Compreh Hlth Ctr   (Japan)

Author keywords

Coronary risk factor; Factor VII; Genotype; Premature myocardial infarction; R353Q polymorphism

Indexed keywords

BLOOD CLOTTING FACTOR 7;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; CORONARY RISK; DISEASE ASSOCIATION; DNA POLYMORPHISM; GENOTYPE; HEART INFARCTION; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; RISK FACTOR;

ADULT; AGE OF ONSET; CASE-CONTROL STUDIES; DNA MUTATIONAL ANALYSIS; FACTOR VIIA; GENE FREQUENCY; GENOTYPE; HUMANS; JAPAN; MALE; MYOCARDIAL INFARCTION; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK;

EID: 3042793206     PISSN: 13469843     EISSN: None     Source Type: Journal    
DOI: 10.1253/circj.68.520     Document Type: Article

References (53)

1. Fuster V, Corti R, Badimon JJ. Therapeutic targets for the treatment of atherothrombosis in the new millennium: Clinical frontiers in atherosclerosis research. Circ J 2002; 66: 783-790.
2. Seligsohn U, Kasper CK, Osterud B, Rapaport SI. Activated factor VII: Presence in factor IX concentrates and persistence in the circulation after infusion. Blood 1979; 53: 828-837.
3. Nakagaki T, Foster DC, Berkner KL, Kisiel W. Initiation of the extrinsic pathway of blood coagulation: Evidence for the tissue factor dependent autoactivation of human coagulation factor VII. Biochemistry 1991; 30: 10819-10824.
4. Morrissey JH, Macik BG, Neuenschwander PF, Comp PC. Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation. Blood 1993; 81: 734-744.
5. Morrissey JH. Tissue factor interactions with factor VII: Measurement and clinical significance of factor VIIa in plasma. Blood Coagul Fibrinol 1995; 6: S14-S19.
6. Meade TW, Mellows S, Brozovic M, Miller GJ, Chakrabarti RR, North WRS, et al. Haemostatic function and ischaemic heart disease: Principal results of the Northwick Park Heart Study. Lancet 1986; 2: 533-537.
7. Meade TW, Ruddock V, Stirling Y, Chakrabarti R, Miller GJ. Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study. Lancet 1993; 342: 1076-1079.
8. Moor E, Silveira A, van't Hooft F, Suontaka AM, Eriksson P, Blomback M, et al. Coagulation factor VII mass and activity in young men with myocardial infarction at a young age: Role of plasma lipoproteins and factor VII genotype. Arterioscler Thromb Vasc Biol 1995; 15: 655-664.
9. Kario K, Miyata T, Sakata T, Matsuo T, Kato H. Fluorogenic assay of activated factor VII: Plasma factor VIIa levels in relation to arterial cardiovascular diseases in Japanese. Arterioscler Thromb 1994; 14: 265-274.
10. Philippou H, Adami A, Amersey RA, Stubbs PJ, Lane DA. A novel specific immunoassay for plasma two-chain factor VIIa: Investigation of FVIIa levels in normal individuals and in patients with acute coronary syndromes. Blood 1997; 89: 767-775.
11. Hoffman CJ, Miller RH, Lawson WE, Hultin MB. Elevation of factor VII activity and mass in young adults at risk of ischemic heart disease. J Am Coll Cardiol 1989; 14: 941-946.
12. de Sousa JC, Azevedo J, Soria C, Barros F, Ribeiro C, Parreira F, et al. Factor VII hyperactivity in acute myocardial thrombosis: A relation to the coagulation activation. Thromb Res 1988; 51: 165-173.
13. Redondo M, Warzke HH, Stucki B, Sulzer I, Biasiutti FD, Binder BR, et al. Coagulation factors II, V, VII, and X, prothrombin gene 20210G→ A transition, and factor V Leiden in coronary artery disease: High factor V clotting activity is an independent risk factor for myocardial infarction. Arterioscler Thromb Vasc Biol 1999; 19: 1020-1025.
14. Broadhurst P, Kelleher C, Hughes L, Imeson JD, Raftery EB. Fibrinogen, factor VII clotting activity and coronary artery disease severity. Atherosclerosis 1990; 85: 169-173.
15. Green F, Kelleher C, Wilkes H, Temple A, Meade T, Humphries S. A common genetic polymorphism associated with lower coagulation factor VII levels in healthy individuals. Arterioscler Thromb 1991; 11: 540-546.
16. Saha N, Liu Y, Heng CK, Hong S, Low PS, Tay JSH. Association of factor VII genotype with plasma factor VII activity and antigen levels in healthy Indian adults and interaction with triglycerides. Arterioscler Thromb 1994; 14: 1923-1927.
17. de Maat MPM, Green F, de Knijff P, Jespersen J, Kluft C. Factor VII polymorphisms in populations with different risks of cardiovascular disease. Arterioscler Thromb Vasc Biol 1997; 17: 1918-1923.
18. Bernardi F, Marchetti G, Pinotti M, Arcieri P, Baroncini C, Papacchini M, et al. Factor VII gene polymorphisms contribute about one third of the factor VII levels variation in plasma. Arterioscler Thromb Vasc Biol 1996; 16: 72-76.
19. Hunault M, Arbini AA, Lopaciuk S, Carew JA, Bauer KA. The Arg353Gln polymorphism reduces the level of cagulation factor VII: In vivo and in vitro studies. Arterioscler Thromb Vasc Biol 1997; 17: 2825-2829.
20. Takamiya O. Genetic polymorphism (Arg353A→Gln) in coagulation factor VII gene and factor VII levels (coagulant activity, antigen and binding ability to tissue factor) in 101 healthy Japanese. Scand J Clin Lab Invest 1995; 55: 211-215.
21. Kario K, Narita N, Matsuo T, Kayaba K, Tsutsumi A, Matsuo M, et al. Genetic determinants of plasma factor VII activity in the Japanese. Thromb Haemost 1995; 73: 617-622.
22. Humphries SE, Lane A, Green FR, Cooper J, Miller GJ. Factor VII coagulant activity and antigen levels in healthy men are determined by interaction between factor VII genotype and plasma triglyceride concentration. Arterioscler Thromb 1994; 14: 193-198.
23. Feng D, Tofler GH, Larson MG, O'Donnell CJ, Lipinska I, Schmitz C, et al. Factor VII gene polymorphism, factor VII levels, and prevalent cardiovascular disease: The Framingham Heart Study. Arterioscler Thromb Vasc Biol 2000; 20: 593-600.
24. Bernardi F, Arcieri P, Bertina RM, Chiarotti F, Corral J, Pinotti M, et al. Contribution of factor VII genotype to activated FVII levels: Differences in genotype frequencies between northern and southern European populations. Arterioscler Thromb Vasc Biol 1997; 17: 2548-2553.
25. Ogawa K, Numao T, Iizuka M, Yanagisawa A, Yoshino H, Ishikawa K, et al. Angiographic and coronary risk factor analyses of Japanese patients with ischemic heart disease before age 40: A multicenter cooperative study. Jpn Circ J 1996; 60: 822-830.
26. Zimmerman FH, Cameron A, Fisher LD, Ng G. Myocardial infarction in young adults: Angiographic characterization, risk factors and prognosis (Coronary Artery Surgery Study Registry). J Am Coll Cardiol 1995; 26: 654-661.
27. Choudhury L, Marsh JD. Myocardial infarction in young patients. Am J Med 1999; 107: 254-261.
28. Yasuda T, Shimizu M, Ino H, Okeie K, Yamaguchi M, Fujino N, et al. Coronary lesion morphology and prognosis in young males with myocardial infarction with or without familial hypercholesterolemia. Jpn Circ J 2001; 65: 247-250.
29. Saigo M, Abe S, Ogawa M, Yamashita T, Biro S, Minagoe S, et al. Imbalance of plasminogen activator inhibitor-1/tissue plasminogen activator and tissue factor/tissue factor pathway inhibitor in young Japanese men with myocardial infarction. Thromb Haemost 2001; 86: 1197-1203.
30. Merlini PA, Ardissino D, Oltrona L, Broccolino M, Coppola R, Mannucci PM. Heightened thrombin formation but normal plasma levels of activated factor VII in patients with acute coronary syndromes. Arterioscler Thromb Vasc Biol 1995; 15: 1675-1679.
31. Heywood DM, Ossei-Gerning N, Grant PJ. Association of factor VII: C levels with environmental and genetic factors in patients with ischaemic heart disease and coronary atheroma characterised by angiography. Thromb Haemost 1996; 76: 161-165.
32. Ardissino D, Mannucci PM, Merlini PA, Duca F, Fetiveau R, Tagliabue L, et al. Prothrombotic genetic risk factors in young survivors of myocardial infarction. Blood 1999; 94: 46-51.
33. Batalla A, Alvarez R, Reguero JR, González P, Alvarez V, Cubero GI, et al. Lack of association between polymorphisms of the coagulation factor VII and myocardial infarction in middle-aged Spanish men. Int J Cardiol 2001; 80: 209-212.
34. Tamaki S, Iwai N, Nakamura Y, Tsujita Y, Kinoshita M. Variation of the factor VII gene and ischemic heart disease in Japanese subjects. Coron Artery Dis 1999; 10: 601-606.
35. Iacoviello L, Di Castelnuovo A, de Knijff P, D'Orazio A, Amore C, Arboretti R, et al. Polymorphisms in the coagulation factor VII gene and the risk of myocardial infarction. N Engl J Med 1998; 338: 79-85.
36. Girelli D, Russo C, Ferraresi P, Olivieri O, Pinotti M, Friso S, et al. Polymorphisms in the factor VII gene and the risk of myocardial infarction in patients with coronary artery disease. N Engl J Med 2000; 343: 774-780.
37. Di Castelnuovo A, D'Orazio A, Amore C, Falanga A, Donati MB, Iacoviello L. The decanucleotide insertion/deletion polymorphism in the promoter region of the coagulation factor VII gene and the risk of familial myocardial infarction. Thromb Res 2000; 98: 9-17.
38. 353 gene. J Am Coll Cardiol 2000; 36: 1520-1525.
39. Li YH, Chen JH, Guo HR, Tsai WC, Chao TH. Genetic risk factors associated with the prognosis of myocardial infarction in young patients. Thromb Haemost 2002; 88: 694-697.
40. Shimokata K, Kondo T, Ohno M, Takeshita K, Inden Y, Iino S, et al. Effects of coagulation factor VII polymorphisms on the coronary artery disease in Japanese: Factor VII polymorphism and coronary disease. Thromb Res 2002; 105: 493-498.
41. Sawano M, Watanabe Y, Ohmura H, Shimada K, Daida H, Mokuno H, et al. Potentially protective effects of the Ser447-Ter mutation of the lipoprotein lipase gene against the development of coronary artery disease in Japanese subjects via a beneficial lipid profile. Jpn Circ J 2001; 65: 310-314.
42. Takezako T, Zhang B, Serikawa T, Fan P, Nomoto J, Saku K. The D allele of the angiotensin-converting enzyme gene and reperfusion-induced ventricular arrhythmias in patients with acute myocardial infarction. Jpn Circ J 2001; 65: 603-609.
43. Taniguchi I, Yamazaki T, Wagatsuma K, Kurusu T, Shimazu Y, Takikawa K, et al. The DD genotype of angiotensin-converting enzyme polymorphism is a risk factor for coronary artery disease and coronary stent restenosis in Japanese patients. Jpn Circ J 2001; 65: 897-900.
44. Siscovick DS, Schwartz SM, Rosendaal FR, Psaty BM. Thrombosis in the young: Effect of atherosclerotic risk factors on the risk of myocardial infarction associated with prothrombotic factors. Thromb Haemost 1997; 78: 7-12.
45. Ridker PM, Vaughan DE, Stampfer MJ, Manson JE, Hennekens CH. Endogenous tissue-type plasminogen activator and risk of myocardial infarction. Lancet 1993; 341: 1165-1168.
46. Thompson SG, Kienast J, Pyke SD, Haverkate F, van de Loo JC. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris: European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. N Engl J Med 1995; 332: 635-641.
47. Hamsten A, Wiman B, de Faire U, Blomback M. Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction. N Engl J Med 1985; 313: 1557-1563.
48. Iacoviello L, Di Castelnuovo A, D'Orazio A, Donati MB. Cigarette smoking doubles the risk of myocardial infarction in carriers of a protective polymorphism in the blood coagulation factor VII gene. Thromb Haemost 1999; 81: 658.
49. Marchetti G, Gemmati D, Patracchini P, Pinotti M, Bernardi F. PCR detection of a repeat polymorphism within the F7 gene. Nucleic Acids Res 1991; 19: 4570.
50. Marchetti G, Patracchini P, Papacchini M, Ferrati M, Bernardi F. A polymorphism in the 5′ region of coagulation factor VII gene (F7) caused by an inserted decanucleotide. Hum Genet 1993; 90: 575-576.
51. Humphries S, Temple A, Lane A, Green F, Cooper J, Miller G. Low plasma levels of factor VIIc and antigen are more strongly associated with the 10 base pair promoter (-323) insertion than the Glutamine 353 variant. Thromb Haemost 1996; 75: 567-572.
52. Dell'Acqua G, Iacoviello L, D'Orazio A, Di Bitondo R, Di Castelnuovo A, Donati MB. A polymorphic cluster in the 5′ region of the human coagulation factor VII gene: Detection, frequency, and linkage disequilibrium. Thromb Res 1997; 88: 445-448.
53. Peyvandi F, Mannucci PM, Bucciarelli P, Zeinali S, Akhavan S, Sacchi E, et al. A novel polymorphism in intron 1a of the human factor VII gene (G73A): Study of a healthy Italian population and of 190 young survivors of myocardial infarction. Br J Haematol 2000; 108: 247-253.